Rallybio Corporation - Common Stock (NQ:RLYB)

15.78 -0.16 (-1.00%)

Streaming Delayed Price Updated: 1:32 PM EDT, Jul 2, 2026 Add to My Watchlist

Price and Volume

Volume	12,377
Open	15.76
Bid (Size)	15.71 (400)
Ask (Size)	15.92 (100)
Prev. Close	15.94
Today's Range	15.70 - 15.99
52wk Range	2.553 - 17.57
Shares Outstanding	37,747,433
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

June 02, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Halper Sadeh LLC is Investigating Whether RLYB, KALV, INM, TMHC are Obtaining Fair Deals for their Shareholders

June 02, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Performance

YTD	+178.9%	+178.9%
1 Month	-6.5%	-6.5%
3 Month	+87.9%	+87.9%
6 Month	+187.5%	+187.5%
1 Year	+497.2%	+497.2%

More News

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Taylor Morrison Home Corporation (NYSE - TMHC), Rallybio Corporation (Nasdaq – RLYB), InMed Pharmaceuticals, Inc. (Nasdaq – INM), KalVista Pharmaceuticals, Inc.

June 02, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

RALLYBIO CORP (NASDAQ:RLYB) Passes Minervini Trend and High Growth Momentum Filters ↗

March 30, 2026

Via Chartmill

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Price for its Shareholders

June 01, 2026

From Halper Sadeh LLC

Via Business Wire

Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement

June 01, 2026

From Rallybio Corporation

Via Business Wire

These stocks are moving in today's session ↗

May 04, 2026

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

May 04, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Monday's session. ↗

May 04, 2026

Via Chartmill

Discover the top movers in Monday's pre-market session. ↗

May 04, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Terns Therapeutics, Inc. (Nasdaq – TERN), Whitestone REIT (NYSE – WSR), Rallybio Corporation (Nasdaq – RLYB), Day One Biopharmaceuticals, Inc. (Nasdaq - DAWN)

April 09, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether RLYB, TALK, UNF are Obtaining Fair Deals for their Shareholders

March 19, 2026

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)

March 18, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Halper Sadeh LLC is Investigating Whether TALK, JTAI, RLYB are Obtaining Fair Deals for their Shareholders

March 17, 2026

From Halper Sadeh LLC

Via GlobeNewswire

Rallybio Investor Alert: Kahn Swick & Foti, LLC Investigates Merger of Rallybio Corporation - RLYB

March 04, 2026

From Kahn Swick & Foti, LLC

Via Business Wire

Monday's session: top gainers and losers ↗

March 02, 2026

Via Chartmill

RLYB Stock Alert: Halper Sadeh LLC is Investigating Whether Rallybio Corporation is Obtaining a Fair Deal for its Shareholders

March 02, 2026

From Halper Sadeh LLC

Via Business Wire

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 02, 2026

Via Chartmill

Rallybio Corporation and Candid Therapeutics Announce Merger Agreement

March 02, 2026

From Candid Therapeutics, Inc.

Via Business Wire

Rallybio Announces Positive Data for RLYB116 Phase 1 Study Demonstrating Complete and Sustained Inhibition of Terminal Complement

February 17, 2026

From Rallybio Corporation

Via Business Wire

Rallybio Announces Reverse Stock Split of Common Stock

February 03, 2026

From Rallybio Corporation

Via Business Wire

RALLYBIO CORP (NASDAQ:RLYB) Reports Q3 2025 Earnings Beat Fueled by Asset Sale and Advances Clinical Pipeline ↗

November 06, 2025

Via Chartmill

Rallybio Reports Third Quarter 2025 Financial Results and Provides Business Updates

November 06, 2025

From Rallybio Corporation

Via Business Wire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 16, 2025

Via Benzinga

Frequently Asked Questions

Is Rallybio Corporation - Common Stock publicly traded?

Yes, Rallybio Corporation - Common Stock is publicly traded.

What exchange does Rallybio Corporation - Common Stock trade on?

Rallybio Corporation - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Rallybio Corporation - Common Stock?

The ticker symbol for Rallybio Corporation - Common Stock is RLYB on the Nasdaq Stock Market

What is the current price of Rallybio Corporation - Common Stock?

The current price of Rallybio Corporation - Common Stock is 15.78

When was Rallybio Corporation - Common Stock last traded?

The last trade of Rallybio Corporation - Common Stock was at 07/02/26 01:32 PM ET

What is the market capitalization of Rallybio Corporation - Common Stock?

The market capitalization of Rallybio Corporation - Common Stock is 595.65M

How many shares of Rallybio Corporation - Common Stock are outstanding?

Rallybio Corporation - Common Stock has 596M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.